Outcome Modifying Genes in Sickle Cell Disease
Short Name |
|
Institution(s) |
Duke University
|
Type of Omics |
|
Approx. Sample Size |
675
|
Disease/Phenotype |
sickle cell disease
|
Starting Phase |
|
dbGaP ID |
|
TOPMed Accession # |
Please see this TOPMed Project's Parent Studies.
|
Omics Center(s) Phase 2 |
Baylor College of Medicine Human Genome Sequencing Center
|
Specify the TOPMed Phase for the Omics Center(s) selected above |
7.1
|
Omics Center Contact |
|
Phases Involved |
|
Populations |
Adult Patients with SCD from NC and GA
|
PI |
|
Co-PI |
|
Contact |
|
Steering Committee Representatives |
|
P&P primary |
|
Project |
OMG_SCD
|
Released |
No
|